These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 19172823

  • 1. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
    Kobashi Y, Oka M.
    Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
    [Abstract] [Full Text] [Related]

  • 2. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
    Kobashi Y, Matsushima T.
    Respiration; 2007 Dec; 74(4):394-400. PubMed ID: 16954651
    [Abstract] [Full Text] [Related]

  • 3. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
    Kobashi Y, Okimoto N, Matsushima T, Shigetou E, Kuraoka T, Takeyama H, Eda R, Yano S, Kobayashi K, Ohnishi T, Mori K, Ueda Y, Moritaka T, Nishimura K, Abe T.
    Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
    [Abstract] [Full Text] [Related]

  • 4. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ, Wu TS, Chiang PC, Lee MH.
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [Abstract] [Full Text] [Related]

  • 5. [Perspective of pulmonary MAC infection treatment].
    Kurashima A.
    Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
    [Abstract] [Full Text] [Related]

  • 6. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
    Sato K, Ebe T.
    Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
    Watanabe M, Hasegawa N, Ishizaka A, Asakura K, Izumi Y, Eguchi K, Kawamura M, Horinouchi H, Kobayashi K.
    Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
    [Abstract] [Full Text] [Related]

  • 9. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG, Gao Z, Fan BD.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [Abstract] [Full Text] [Related]

  • 10. Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines.
    Kobashi Y, Matsushima T.
    J Infect Chemother; 2004 Feb; 10(1):25-30. PubMed ID: 14991514
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H.
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [Abstract] [Full Text] [Related]

  • 13. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ.
    Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA.
    Faruqi S, Kastelik JA, McGivern DV.
    Eur J Intern Med; 2008 May; 19(3):216-8. PubMed ID: 18395168
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis].
    Kuwabara K, Watanabe Y, Wada K, Tsuchiya T.
    Kekkaku; 2004 Feb; 79(2):39-46. PubMed ID: 15031998
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
    Kobashi Y, Matsushima T.
    Intern Med; 2003 Aug; 42(8):670-5. PubMed ID: 12924489
    [Abstract] [Full Text] [Related]

  • 19. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
    Tanaka E.
    Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140
    [No Abstract] [Full Text] [Related]

  • 20. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
    Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A.
    Am J Respir Crit Care Med; 2006 Jun 01; 173(11):1283-9. PubMed ID: 16514112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.